News

  • Femtech in 2025: A year of acceleration, and what data signals for 2026

    By Celine Vignal, co-founder of Seesaw Health The past year marked a turning point in femtech. After a decade of steady progress, 2025 delivered a wave of innovations that pushed women’s health technology into a more mature, data-driven, and clinically integrated era. From AI-enhanced hormone analytics to nervous-system biofeedback, companies shifted away from generic wellness [...]

  • Round up: First wearable detects symptoms of perimenopause, and more

    Femtech World explores the latest business developments in the world of women's health. First wearable detects and decodes the symptoms of perimenopause AI-driven women's health company, IdentifyHer, has launched Peri, the world's first wearable designed to detect and decode symptoms of perimenopause. "75 per cent of perimenopausal women experience life-disrupting symptoms, yet perimenopause is treated [...]

  • Acceptable use vs exploitation with ‘free’ digital health tools

    By Wolfgang Hackl, CEO, OncoGenomX Inc., Allschwil, Switzerland “Free” digital health tools are rarely free. In most cases the user – healthy or patient - pay with something far more valuable than a subscription fee: intimate, high-granularity data about their bodies, behaviours, and vulnerabilities. As digital health platforms grow into critical infrastructure for care, research [...]

  • Human Health raises £4.1m for precision care

    Human Health has raised £4.1m seed funding to expand its precision health platform for patients with chronic conditions and accelerate UK rollout. The company’s “Precision Health OS” is an operating system-style platform that uses patient-reported data and AI to tailor care. Patients can track symptoms, treatments and routines, detect patterns and share doctor-ready reports. More [...]

  • Femtech firm launches genetic test for perimenopause

    A new commercially available genetic test for perimenopausal women has been launched by femtech firm Willbe.  The FemGene test is aimed at decoding "how women uniquely experience perimenopause and respond to bioidentical hormone therapy (BHRT)". Perimenopause, affecting over 1 billion women globally, remains one of the most underserved areas of healthcare, WIllbe says. Standard approaches , [...]

  • What’s ‘normal’? The hidden burden of heavy menstrual bleeding

    By Zara Liew, director of clinical partnerships, Lindus Health Hosted by Lindus Health co-CEO Meri Beckwith, Off Protocol is the podcast that challenges the status quo of clinical trials. Each episode opens the door to honest conversations with experts across the industry — sharing real stories, confronting persistent challenges, and exploring what it takes to [...]

  • CardMedic and LanguageLine announce app integration

    CardMedic, the digital platform transforming clinician and patient communication, has announced a major integration with LanguageLine Solutions, the global leader in on-demand interpretation. The partnership brings one-click access to live, professional video and audio interpreters in more than 240 languages directly within the CardMedic app. The integration will help clinicians deliver safe, inclusive, and human-centered [...]

  • Study finds gender gap in knee injuries

    One of the largest MRI studies comparing knee injuries by sex has found age-related differences in patterns. The findings could be used to improve risk assessment and develop early intervention strategies. Researchers analysed 13,549 consecutive routine knee MRI exams performed between 2019 and 2024 at four outpatient radiology facilities affiliated with Johns Hopkins Hospital in [...]

  • Global disparities found in endometriosis care guidance

    An analysis has found significant geographical gaps in endometriosis care guidance worldwide. The condition affects an estimated 190 million women globally, with research indicating a gap of up to 12 years between symptom onset and diagnosis. It has also been identified as one of the main causes of a 75 million disability-adjusted life-year gender health [...]

  • UK menstrual tracking app launches beta phase

    Bristol start-up Melody launches its beta phase of a menstrual tracking app offering personalised insights for women throughout their menstrual cycles. The app, developed in response to what its creators describe as limitations in fertility-focused tracking tools, aims to help users understand hormonal patterns through daily check-ins and evidence-based lifestyle guidance. Melody’s approach centres on [...]